BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33441309)

  • 21. Transcriptome analysis of potential candidate genes and molecular pathways in colitis-associated colorectal cancer of Mkp-1-deficient mice.
    Hammad A; Zheng ZH; Namani A; Elshaer M; Wang XJ; Tang X
    BMC Cancer; 2021 May; 21(1):607. PubMed ID: 34034704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation-induced colon cancer in uPA-deficient mice is associated with a deregulated expression of Notch signaling pathway components.
    Afaloniati H; Karagiannis GS; Karavanis E; Psarra TA; Karampatzakis-Kouritas A; Poutahidis T; Angelopoulou K
    Mol Cell Biochem; 2020 Jan; 464(1-2):181-191. PubMed ID: 31758376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8
    Rotman J; Heeren AM; Gassama AA; Lougheed SM; Pocorni N; Stam AGM; Bleeker MCG; Zijlmans HJMAA; Mom CH; Kenter GG; Jordanova ES; de Gruijl TD
    Clin Cancer Res; 2020 Jul; 26(14):3791-3802. PubMed ID: 32220890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcription factor Etv6 regulates functional differentiation of cross-presenting classical dendritic cells.
    Lau CM; Tiniakou I; Perez OA; Kirkling ME; Yap GS; Hock H; Reizis B
    J Exp Med; 2018 Sep; 215(9):2265-2278. PubMed ID: 30087163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8
    Cagnoni AJ; Giribaldi ML; Blidner AG; Cutine AM; Gatto SG; Morales RM; Salatino M; Abba MC; Croci DO; Mariño KV; Rabinovich GA
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
    Cancel JC; Crozat K; Dalod M; Mattiuz R
    Front Immunol; 2019; 10():9. PubMed ID: 30809220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model.
    Baumgart A; Mazur PK; Anton M; Rudelius M; Schwamborn K; Feuchtinger A; Behnke K; Walch A; Braren R; Peschel C; Duyster J; Siveke JT; Dechow T
    Oncogene; 2015 Jan; 34(5):578-88. PubMed ID: 24509876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration.
    He F; Wu Z; Liu C; Zhu Y; Zhou Y; Tian E; Rosin-Arbesfeld R; Yang D; Wang MW; Zhu D
    Signal Transduct Target Ther; 2024 May; 9(1):139. PubMed ID: 38811552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model.
    Jack AM; Aydin N; Montenegro G; Alam K; Wallack M
    J Surg Res; 2007 May; 139(2):164-9. PubMed ID: 17275030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
    Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type I IFN Activating Type I Dendritic Cells for Antitumor Immunity.
    Liang Y; Hannan R; Fu YX
    Clin Cancer Res; 2021 Jul; 27(14):3818-3824. PubMed ID: 33692027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twist1 promotes dendritic cell-mediated antitumor immunity.
    Luo Y; Chen J; Liu M; Chen S; Su X; Su J; Zhao C; Han Z; Shi M; Ma X; Huang H
    Exp Cell Res; 2020 Jul; 392(2):112003. PubMed ID: 32278689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch2 signaling is required for potent antitumor immunity in vivo.
    Sugimoto K; Maekawa Y; Kitamura A; Nishida J; Koyanagi A; Yagita H; Kojima H; Chiba S; Shimada M; Yasutomo K
    J Immunol; 2010 May; 184(9):4673-8. PubMed ID: 20351182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance.
    Meyer MA; Baer JM; Knolhoff BL; Nywening TM; Panni RZ; Su X; Weilbaecher KN; Hawkins WG; Ma C; Fields RC; Linehan DC; Challen GA; Faccio R; Aft RL; DeNardo DG
    Nat Commun; 2018 Mar; 9(1):1250. PubMed ID: 29593283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of EMT Factor ZEB1 in cDC1 "MutuDC Line" Mediated Induction of Th1 Immune Response.
    Smita S; Ahad A; Ghosh A; Biswas VK; Koga MM; Gupta B; Acha-Orbea H; Raghav SK
    Front Immunol; 2018; 9():2604. PubMed ID: 30483264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells.
    Kirkling ME; Cytlak U; Lau CM; Lewis KL; Resteu A; Khodadadi-Jamayran A; Siebel CW; Salmon H; Merad M; Tsirigos A; Collin M; Bigley V; Reizis B
    Cell Rep; 2018 Jun; 23(12):3658-3672.e6. PubMed ID: 29925006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis.
    Burgueño JF; Fritsch J; González EE; Landau KS; Santander AM; Fernández I; Hazime H; Davies JM; Santaolalla R; Phillips MC; Diaz S; Dheer R; Brito N; Pignac-Kobinger J; Fernández E; Conner GE; Abreu MT
    Gastroenterology; 2021 Feb; 160(3):797-808.e6. PubMed ID: 33127391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.
    del Rio ML; Rodriguez-Barbosa JI; Kremmer E; Förster R
    J Immunol; 2007 Jun; 178(11):6861-6. PubMed ID: 17513734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathobiology of Notch2 in lung cancer.
    Motooka Y; Fujino K; Sato Y; Kudoh S; Suzuki M; Ito T
    Pathology; 2017 Aug; 49(5):486-493. PubMed ID: 28666642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.